Pasar al contenido principal

DESORGANIZACION MOLECULAR DURANTE LA MUTAGENESIS LETAL DE SARS-COV-2: AFECTACION DE REGIONES DE RNA ESTRUCTURADAS Y NO ESTRUCTURADAS

PID2020-113888RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 29
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing

  • Llorens-Revull, Meritxell|||0000-0002-8671-8907
  • Martínez-González, Brenda|||0000-0002-4482-5181
  • Quer, Josep|||0000-0003-0014-084X
  • Esteban Mur, Juan Ignacio|||0000-0001-5085-917X
  • Núñez-Moreno, Gonzalo|||0000-0001-5982-570X
  • Minguez, Pablo|||0000-0003-4099-9421
  • Burgui, Idoia
  • Ramos-Ruiz, Ricardo|||0000-0002-6331-9786
  • Soria Benito, María Eugenia|||0000-0002-4719-3351
  • Rico, Angie
  • Riveiro Barciela, Mar|||0000-0001-9309-2052
  • Sauleda, Silvia|||0000-0001-7343-9557
  • Piron, Maria|||0000-0001-6858-9374
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Ramírez Serra, Clara|||0000-0001-8971-1711
  • Camós Anguila, Sílvia|||0000-0002-0478-8494
  • Domingo, Esteban
  • Bes, Marta|||0000-0001-6103-072X
  • Perales Viejo, Celia|||0000-0003-1618-1937
  • Costafreda Salvany, Maria Isabel|||0000-0002-3114-3034
MicroRNAs (miRNAs) encapsulated in extracellular vesicles (EVs) are potential diagnostic and prognostic biomarkers. However, discrepancies in miRNA patterns and their validation are still frequent due to differences in sample origin, EV isolation, and miRNA sequencing methods. The aim of the present study is to find a reliable EV isolation method for miRNA sequencing, adequate for clinical application. To this aim, two comparative studies were performed in parallel with the same human plasma sample: (i) isolation and characterization of EVs obtained using three procedures: size exclusion chromatography (SEC), iodixanol gradient (GRAD), and its combination (SEC+GRAD) and (ii) evaluation of the yield of miRNA sequences obtained using NextSeq 500 (Illumina) and three miRNA library preparation protocols: NEBNext, NEXTFlex, and SMARTer smRNA-seq. The conclusion of comparison (i) is that recovery of the largest amount of EVs and reproducibility were attained with SEC, but GRAD and SEC+GRAD yielded purer EV preparations. The conclusion of (ii) is that the NEBNext library showed the highest reproducibility in the number of miRNAs recovered and the highest diversity of miRNAs. These results render the combination of GRAD EV isolation and NEBNext library preparation for miRNA retrieval as adequate for clinical applications using plasma samples.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

SARS-CoV-2 Point Mutation and Deletion Spectra, and Their Association with Different Disease Outcome

  • Martínez-González, Brenda
  • Soria, María Eugenia
  • Vázquez-Sirvent, Lucía
  • Ferrer-Orta, Cristina
  • Lobo-Vega, Rebeca
  • Mínguez, Pablo
  • Fuente, Lorena de la
  • Llorens, Carlos
  • Soriano, Beatriz
  • Ramos-Ruiz, Ricardo
  • Cortón, Marta
  • López-Rodríguez, Rosario
  • García-Crespo, Carlos
  • Gallego, Isabel
  • Ávila, Ana Isabel de
  • Gómez-Castilla, Jordi
  • Enjuanes Sánchez, Luis
  • Salar-Vidal, Llanos
  • Esteban, Jaime
  • Fernández-Roblas, Ricardo
  • Gadea, Ignacio
  • Ayuso, Carmen
  • Ruíz-Hornillos, Javier
  • Verdaguer, Núria
  • Domingo, Esteban
  • Perales, Celia
Mutant spectra of RNA viruses are important to understand viral pathogenesis, and response to selective pressures. There is a need to characterize the complexity of mutant spectra in coronaviruses sampled from infected patients. In particular, the possible relationship between SARS-CoV-2 mutant spectrum complexity and disease associations has not been established. In the present study, we report an ultra-deep sequencing (UDS) analysis of the mutant spectrum of amplicons from the nsp12 (polymerase)- and spike (S)-coding regions of thirty nasopharyngeal isolates (diagnostic samples) of SARS-CoV-2 of the first COVID-19 pandemic wave (Madrid, Spain, April 2020) classified according to the severity of ensuing COVID-19. Low frequency mutations and deletions, counted relative to the consensus sequence of the corresponding isolate, were overwhelmingly abundant. We show that the average number of different point mutations, mutations per haplotype and several diversity indices was significantly higher in SARS-CoV-2 isolated from patients who developed mild disease than in those associated with moderate or severe disease (exitus). No such bias was observed with RNA deletions. Location of amino acid substitutions in the three dimensional structures of nsp12 (polymerase) and S suggest significant structural or functional effects. Thus, patients who develop mild symptoms may be a richer source of genetic variants of SARS-CoV-2 than patients with moderate or severe COVID-19., This work was supported by Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (COVID-19 Research Call COV20/00181), and co‐financed by European Development Regional Fund ‘A way to achieve Europe’. The work was also supported by grants CSIC-COV19-014 from Consejo Superior de Investigaciones Científicas (CSIC), project 525/C/2021 from Fundació La Marató de TV3, PID2020-113888RB-I00 from Ministerio de Ciencia e Innovación, BFU2017-91384-EXP from Ministerio de Ciencia, Innovación y Universidades (MCIU), PI18/00210 and PI21/00139 from Instituto de Salud Carlos III and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). C.P., M.C. and P.M. are supported by the Miguel Servet programme of the Instituto de Salud Carlos III (CPII19/00001, CPII17/00006 and CP16/00116, respectively) cofinanced by the European Regional Development Fund (ERDF). CIBERehd (Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas) is funded by Instituto de Salud Carlos III. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo) cofinanced by Fondo Social Europeo (FSE). R.L.- V. is supported by predoctoral contract PEJD-2019-PRE/BMD-16414 from Comunidad de Madrid. C.G.-C. is supported by predoctoral contract PRE2018-083422 from MCIU. BS was supported by a predoctoral research fellowship (Doctorados Industriales, DI-17- 09134) from Spanish MINECO, No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations

  • Martínez-González, Brenda
  • Soria, María Eugenia
  • Vázquez-Sirvent, Lucía
  • Ferrer-Orta, Cristina
  • Lobo-Vega, Rebeca
  • Mínguez, Pablo
  • Fuente, Lorena de la
  • Llorens, Carlos
  • Soriano, Beatriz
  • Ramos-Ruiz, Ricardo
  • Cortón, Marta
  • López-Rodríguez, Rosario
  • García-Crespo, Carlos
  • Somovilla, Pilar
  • Durán-Pastor, Antoni
  • Gallego, Isabel
  • Ávila, Ana Isabel de
  • Delgado, Soledad
  • Morán, Federico
  • López-Galíndez, Cecilio
  • Gómez-Castilla, Jordi
  • Enjuanes Sánchez, Luis
  • Salar-Vidal, Llanos
  • Esteban-Muñoz, Mario
  • Esteban, Jaime
  • Fernández-Roblas, Ricardo
  • Gadea, Ignacio
  • Ayuso, Carmen
  • Ruíz-Hornillos, Javier
  • Verdaguer, Núria
  • Domingo, Esteban
  • Perales, Celia
Populations of RNA viruses are composed of complex and dynamic mixtures of variant genomes that are termed mutant spectra or mutant clouds. This applies also to SARS-CoV-2, and mutations that are detected at low frequency in an infected individual can be dominant (represented in the consensus sequence) in subsequent variants of interest or variants of concern. Here we briefly review the main conclusions of our work on mutant spectrum characterization of hepatitis C virus (HCV) and SARS-CoV-2 at the nucleotide and amino acid levels and address the following two new questions derived from previous results: (i) how is the SARS-CoV-2 mutant and deletion spectrum composition in diagnostic samples, when examined at progressively lower cut-off mutant frequency values in ultra-deep sequencing; (ii) how the frequency distribution of minority amino acid substitutions in SARS-CoV-2 compares with that of HCV sampled also from infected patients. The main conclusions are the following: (i) the number of different mutations found at low frequency in SARS-CoV-2 mutant spectra increases dramatically (50- to 100-fold) as the cut-off frequency for mutation detection is lowered from 0.5% to 0.1%, and (ii) that, contrary to HCV, SARS-CoV-2 mutant spectra exhibit a deficit of intermediate frequency amino acid substitutions. The possible origin and implications of mutant spectrum differences among RNA viruses are discussed., This work was supported by Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (COVID-19 Research Call COV20/00181), and co-financed by European Development Regional Fund ‘A way to achieve Europe’. The work was also supported by grants CSIC-COV19-014 from Consejo Superior de Investigaciones Científicas (CSIC), project 525/C/2021 from Fundació La Marató de TV3, PID2020-113888RB-I00 from Ministerio de Ciencia e Innovación, BFU2017-91384-EXP from Ministerio de Ciencia, Innovación y Universidades (MCIU), PI18/00210 and PI21/00139 from Instituto de Salud Carlos III, and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). C.P., M.C., and P.M. are supported by the Miguel Servet programme of the Instituto de Salud Carlos III (CPII19/00001, CPII17/00006, and CP16/00116, respectively) cofinanced by the European Regional Development Fund (ERDF). CIBERehd (Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas) is funded by Instituto de Salud Carlos III. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo) cofinanced by Fondo Social Europeo (FSE). R.L.-V. is supported by predoctoral contract PEJD-2019-PRE/BMD-16414 from Comunidad de Madrid. C.G.-C. is supported by predoctoral contract PRE2018-083422 from MCIU. P.S. is supported by postdoctoral contract “Margarita Salas” CA1/RSUE/2021 from MCIU. B.S. was supported by a predoctoral research fellowship (Doctorados Industriales, DI-17-09134) from Spanish MINECO., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

SARS-CoV-2 mutant spectra reveal differences between COVID-19 severity categories

  • Martínez-González, Brenda
  • Soria, María Eugenia
  • Vázquez-Sirvent, Lucía
  • Ferrer-Orta, Cristina
  • Lobo-Vega, Rebeca
  • Mínguez, Pablo
  • Fuente, Lorena de la
  • Llorens, Carlos
  • Soriano, Beatriz
  • Ramos-Ruiz, Ricardo
  • Cortón, Marta
  • López-Rodríguez, Rosario
  • García-Crespo, Carlos
  • Somovilla, Pilar
  • Durán-Pastor, Antoni
  • Gallego, Isabel
  • Ávila, Ana Isabel de
  • Delgado, Soledad
  • Morán, Federico
  • López-Galíndez, Cecilio
  • Gómez-Castilla, Jordi
  • Enjuanes Sánchez, Luis
  • Salar-Vidal, Llanos
  • Esteban-Muñoz, Mario
  • Esteban, Jaime
  • Fernández-Roblas, Ricardo
  • Gadea, Ignacio
  • Ayuso, Carmen
  • Ruíz-Hornillos, Javier
  • Verdaguer, Núria
  • Domingo, Esteban
  • Perales, Celia
Trabajo presentado en el XVI Congreso Nacional de Virología, celebrado en Málaga (España) del 06 al 09 de septiembre de 2022., RNA virus populations are composed of complex mixtures of genomes that are termed mutant spectra. SARS-CoV-2 replicates as a viral quasispecies, and mutations that are detected at low frequencies in a host can be dominant in subsequent variants. We have studied mutant spectrum complexities of SARS-CoV-2 populations derived from thirty nasopharyngeal swabs of patients infected during the first wave (April 2020) in the Hospital Universitario Fundación Jiménez Díaz. The patients were classified according to the COVID-19 severity in mild (non-hospitalized), moderate (hospitalized) and exitus (hospitalized with ICU admission and who passed away due to COVID-19). Using ultra-deep sequencing technologies (MiSeq, Illumina), we have examined four amplicons of the nsp12 (polymerase)-coding region and two amplicons of the spike-coding region. Ultra-deep sequencing data were analyzed with different cut-off frequency for mutation detection. Average number of different point mutations, mutations per haplotype and several diversity indices were significantly higher in SARS-CoV-2 isolated from patients who developed mild disease. A feature that we noted in the SARS-CoV-2 mutant spectra from diagnostic samples is the remarkable absence of mutations at intermediate frequencies, and an overwhelming abundance of mutations at frequencies lower than 10%. Thus, the decrease of the cut-off frequency for mutation detection from 0.5% to 0.1% revealed an increasement (50- to 100 fold) in the number of different mutations. The significantly higher frequency of mutations in virus from patients displaying mild than moderate or severe disease was maintained with the 0.1% cut- off frequency. To evaluate whether the frequency repertoire of amino acid substitutions differed between SARS-CoV-2 and the well characterized hepatitis C virus (HCV), we performed a comparative study of mutant spectra from infected patients using the same bioinformatics pipelines. HCV did not show the deficit of intermediate frequency substitutions that was observed with SARS-CoV-2. This difference was maintained when two functionally equivalent proteins, the corresponding viral polymerases, were compared. In conclusion, SARS-CoV-2 mutant spectra are rich reservoirs of mutants, whose complexity is not uniform among clinical isolates. Virus from patients who developed mild disease may be a source of new variants that may acquire epidemiological relevance., This work was supported by Instituto de Salud Carlos III, Spanish Ministry of Science and In-novation (COVID-19 Research Call COV20/00181), and co-financed by European Development Regional Fund ‘A way to achieve Europe’. The work was also supported by grants CSIC-COV19-014 from Consejo Superior de Investigaciones Científicas (CSIC), project 525/C/2021 from Fundació La Marató de TV3, PID2020-113888RB-I00 from Ministerio de Ciencia e Innovación, BFU2017-91384-EXP from Ministerio de Ciencia, Innovación y Universidades (MCIU), PI18/00210 and PI21/00139 from Instituto de Salud Carlos III, and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). C.P., M.C., and P.M. are supported by the Miguel Servet programme of the Instituto de Salud Carlos III (CPII19/00001, CPII17/00006, and CP16/00116, respectively) co-financed by the European Regional Development Fund (ERDF). CIBERehd (Centro de Investi-gación en Red de Enfermedades Hepáticas y Digestivas) is funded by Instituto de Salud Carlos III. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo) cofinanced by Fondo Social Europeo (FSE). R.L.-V. is supported by predoctoral contract PEJD-2019-PRE/BMD-16414 from Comunidad de Madrid. C.G.-C. is sup-ported by predoctoral contract PRE2018-083422 from MCIU. BS was supported by a predoctoral research fellowship (Doctorados Industriales, DI-17-09134) from Spanish MINECO.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Guanosine inhibits hepatitis C virus replication and increases indel frequencies, associated with altered intracellular nucleotide pools

  • Sabariegos, Rosario
  • Ortega-Prieto, Ana M.
  • Díaz-Martínez, Luis
  • Grande-Pérez, Ana
  • García-Crespo, Carlos
  • Gallego, Isabel
  • Ávila, Ana Isabel de
  • Albentosa González, Laura
  • Soria, María Eugenia
  • Gastaminza, Pablo
  • Domingo, Esteban
  • Perales, Celia
In the course of experiments aimed at deciphering the inhibition mechanism of mycophenolic acid and ribavirin in hepatitis C virus (HCV) infection, we observed an inhibitory effect of the nucleoside guanosine (Gua). Here, we report that Gua, and not the other standard nucleosides, inhibits HCV replication in human hepatoma cells. Gua did not directly inhibit the in vitro polymerase activity of NS5B, but it modified the intracellular levels of nucleoside di- and tri-phosphates (NDPs and NTPs), leading to deficient HCV RNA replication and reduction of infectious progeny virus production. Changes in the concentrations of NTPs or NDPs modified NS5B RNA polymerase activity in vitro, in particular de novo RNA synthesis and template switching. Furthermore, the Gua-mediated changes were associated with a significant increase in the number of indels in viral RNA, which may account for the reduction of the specific infectivity of the viral progeny, suggesting the presence of defective genomes. Thus, a proper NTP:NDP balance appears to be critical to ensure HCV polymerase fidelity and minimal production of defective genomes., CP is supported by the Miguel Servet program (grants CP14/00121 and CP19/00001) of the Instituto de Salud Carlos III cofinanced by FEDER. CP has received funding from Ministerio de Ciencia, Innovacio´n y Universidades (grant BFU2017-91384-EXP), from Instituto de Salud Carlos III (grants PI18/00210 and PI21/00139), from Fundación La Marato´ (grant 525/C/2021), and from CSIC (grant CSIC-COV19-014). ED has received funding from CIBERehd (Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III), from Ministerio de Economía y Competitividad (grants SAF2014-52400-R, SAF2017-87846-R, and PID2020-113888RB-I00), and from Comunidad de Madrid/FEDER (grants S2013/ABI-2906 PLATESA, and S2018/BAA-4370 PLATESA2). AM has received funding from Ministerio de Economía y Competitividad (grants SAF2016-80451-P, PID2019-106068GB-I00, EQC2018-004420-P, and EQC2018-004631-P), and Plan Propio of Universidad de Castilla-La Mancha. A.G-P and L.DM have received funding from Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Junta de Andalucía, cofinanced by FEDER and FSE (grants BIO-264, and P10-CVI-6561) and Plan Propio of Universidad de Málaga., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Vaccine breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota, and Omicron

  • Martínez-González, Brenda
  • Vázquez-Sirvent, Lucía
  • Soria, María Eugenia
  • Mínguez, Pablo
  • Salar-Vidal, Llanos
  • García-Crespo, Carlos
  • Gallego, Isabel
  • Ávila, Ana Isabel de
  • Llorens, Carlos
  • Soriano, Beatriz
  • Ramos-Ruiz, Ricardo
  • Esteban, Jaime
  • Fernández-Roblas, Ricardo
  • Gadea, Ignacio
  • Ayuso, Carmen
  • Ruíz-Hornillos, Javier
  • Pérez-Jorge, Concepción
  • Domingo, Esteban
  • Perales, Celia
Replication of SARS-CoV-2 in the human population is defined by distributions of mutants that are present at different frequencies within the infected host and can be detected by ultra-deep sequencing techniques. In this study, we examined the SARS-CoV-2 mutant spectra of amplicons from the spike-coding (S-coding) region of 5 nasopharyngeal isolates derived from patients with vaccine breakthrough. Interestingly, all patients became infected with the Alpha variant, but amino acid substitutions that correspond to the Delta Plus, Iota, and Omicron variants were present in the mutant spectra of the resident virus. Deep sequencing analysis of SARS-CoV-2 from patients with vaccine breakthrough revealed a rich reservoir of mutant types and may also identify tolerated substitutions that can be represented in epidemiologically dominant variants., This work was supported by the Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (COVID-19 Research Call COV20/00181) and co-financed by the European Development Regional Fund “A way to achieve Europe.” The work was also supported by grants CSIC-COV19-014 from the CSIC, project 525/C/2021 from the Fundació La Marató de TV3; PID2020-113888RB-I00 from the Ministerio de Ciencia e Innovación; BFU2017-91384-EXP from the Ministerio de Ciencia, Innovación y Universidades (MCIU);PI18/00210 and PI21/00139 from the Instituto de Salud Carlos III; and S2018/BAA-4370 (PLATESA2) from the Comunidad de Madrid/ FEDER. This research work was also funded by the European Commission – NextGenerationEU (regulation EU 2020/2094), through the CSIC’s Global Health Platform (PTI Salud Global). CP and PM are supported by the Miguel Servet programme of the Instituto de Salud Carlos III (CPII19/00001 and CP16/00116, respectively), cofinanced by the European Regional Development Fund (ERDF). CIBERehd is funded by the Instituto de Salud Carlos III. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). BMG is supported by predoctoral contract PFIS FI19/00119 from the Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo), cofinanced by the Fondo Social Europeo (FSE). CGC is supported by predoctoral contract PRE2018- 083422 from the MCIU. BS was supported by a predoctoral research fellowship (Doctorados Industriales, DI-17-09134) from the Spanish Ministry of Economy and Competitiveness (MINECO)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Efficacy decrease of antiviral agents when administered to ongoing hepatitis C virus infections in cell culture

  • García-Crespo, Carlos
  • Vázquez-Sirvent, Lucía
  • Somovilla, Pilar
  • Soria, María Eugenia
  • Gallego, Isabel
  • Ávila, Ana Isabel de
  • Martínez-González, Brenda
  • Durán-Pastor, Antoni
  • Domingo, Esteban
  • Perales, Celia
We report a quantification of the decrease of effectiveness of antiviral agents directed to hepatitis C virus, when the agents are added during an ongoing infection in cell culture vs. when they are added at the beginning of the infection. Major determinants of the decrease of inhibitory activity are the time post-infection of inhibitor administration and viral replicative fitness. The efficacy decrease has been documented with antiviral assays involving the combination of the direct-acting antiviral agents, daclatasvir and sofosbuvir, and with the combination of the lethal mutagens, favipiravir and ribavirin. The results suggest that strict antiviral effectiveness assays in preclinical trials may involve the use of high fitness viral populations and the delayed administration of the agents, relative to infection onset., This work was supported by Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (COVID-19 Research Call COV20/00181) and cofinanced by European Development Regional Fund A way to achieve Europe and grants CSIC-COV19-014 from Consejo Superior de Investigaciones Científicas (CSIC), project 525/C/2021 from Fundació La Marató de TV3, PID2020-113888RB-I00 from Ministerio de Ciencia e Innovación, BFU2017-91384-EXP from Ministerio de Ciencia, Innovación y Universidades (MCIU), PI18/00210 and PI21/00139 from Instituto de Salud Carlos III, and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). This research work was also funded by the European Commission NextGenerationEU (Regulation EU 2020/2094), through the CSIC's Global Health Platform (PTI Salud Global). CP was supported by the Miguel Servet Program of the Instituto de Salud Carlos III (CP14/00121 and CPII19/00001), cofinanced by the European Regional Development Fund (ERDF). Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) is funded by Instituto de Salud Carlos III. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). CG-C was supported by predoctoral contract PRE2018-083422 from MCIU. PS was supported by postdoctoral contract Margarita Salas CA1/RSUE/2021 from MCIU. BM-G was supported by predoctoral contract PFIS FI19/00119 from ISCIII, cofinanced by Fondo Social Europeo (FSE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Quasispecies fitness partition to characterize the molecular status of a viral population. Negative effect of early ribavirin discontinuation in a chronically infected HEV Ppatient

  • Gregori, Josep
  • Colomer-Castell, Sergi
  • Campos, Carolina
  • Ibañez-Lligoña, Marta
  • García-Cehic, Damir
  • Rando, Ariadna
  • Adombie, Caroline Melanie
  • Pintó, Rosa María
  • Guix, Susana
  • Bosch, Albert
  • Domingo, Esteban
  • Gallego, Isabel
  • Perales, Celia
  • Cortese, María Francesca
  • Tabernero, David
  • Buti, María
  • Riveiro-Barciela, Mar
  • Esteban, Juan Ignacio
  • Rodríguez-Frías, Francisco
  • Quer, Josep
The changes occurring in viral quasispecies populations during infection have been monitored using diversity indices, nucleotide diversity, and several other indices to summarize the quasispecies structure in a single value. In this study, we present a method to partition quasispecies haplotypes into four fractions according to their fitness: the master haplotype, rare haplotypes at two levels (those present at <0.1%, and those at 0.1–1%), and a fourth fraction that we term emerging haplotypes, present at frequencies >1%, but less than that of the master haplotype. We propose that by determining the changes occurring in the volume of the four quasispecies fitness fractions together with those of the Hill number profile we will be able to visualize and analyze the molecular changes in the composition of a quasispecies with time. To develop this concept, we used three data sets: a technical clone of the complete SARS-CoV-2 spike gene, a subset of data previously used in a study of rare haplotypes, and data from a clinical follow-up study of a patient chronically infected with HEV and treated with ribavirin. The viral response to ribavirin mutagenic treatment was selection of a rich set of synonymous haplotypes. The mutation spectrum was very complex at the nucleotide level, but at the protein (phenotypic/functional) level the pattern differed, showing a highly prevalent master phenotype. We discuss the putative implications of this observation in relation to mutagenic antiviral treatment., This study was partially supported by Plan Estratègic de Recerca i Innovació en Salut (PERIS)—Direcció General de Recerca i Innovació en Salut (DGRIS), Catalan Health Ministry, Generalitat de Catalunya; Centro para el Desarrollo Tecnológico Industrial (CDTI) from the Spanish Ministry of Economy and Business, grant number IDI-20200297; grant PI19/00301 from Instituto de Salud Carlos III cofinanced by the European Regional Development Fund (ERDF), and Gilead’s biomedical research project GLD21/00006. Work at CBMSO in Madrid was supported by grant PID2020-113888RB-100 from Ministerio de Ciencia e Innovación and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The International Virus Bioinformatics Meeting 2022

  • Hufsky, Franziska
  • Beslic, Denis
  • Boeckaerts, Dimitri
  • Duchêne, Sebastián
  • González-Tortuero, Enrique
  • Gruber, Andreas J.
  • Guo, Jiarong
  • Jansen, Daan
  • Juma, John
  • Kongkitimanon, Kunaphas
  • Luque, Antoni
  • Ritsch, Muriel
  • Lencioni Lovate, Gabriel
  • Nishimura, Luca
  • Pas, Célia
  • Domingo, Esteban
  • Hodcroft, Emma B.
  • Lemey, Philippe
  • Sullivan, Matthew B.
  • Weber, Friedemann
  • González-Candelas, Fernando
  • Krautwurst, Sarah
  • Pérez-Cataluña, Alba
  • Randazzo, Walter
  • Sánchez Moragas, Gloria
  • Marz, Manja
This article belongs to the Special Issue Virus Bioinformatics 2022. This Special Issue is published alongside the International Virus Bioinformatics Meeting 2022 (ViBioM 2022) taking place in spring 2022 in Valencia, Spain., The International Virus Bioinformatics Meeting 2022 took place online, on 23-25 March 2022, and has attracted about 380 participants from all over the world. The goal of the meeting was to provide a meaningful and interactive scientific environment to promote discussion and collaboration and to inspire and suggest new research directions and questions. The participants created a highly interactive scientific environment even without physical face-to-face interactions. This meeting is a focal point to gain an insight into the state-of-the-art of the virus bioinformatics research landscape and to interact with researchers in the forefront as well as aspiring young scientists. The meeting featured eight invited and 18 contributed talks in eight sessions on three days, as well as 52 posters, which were presented during three virtual poster sessions. The main topics were: SARS-CoV-2, viral emergence and surveillance, virus-host interactions, viral sequence analysis, virus identification and annotation, phages, and viral diversity. This report summarizes the main research findings and highlights presented at the meeting., This research was funded by CSIC grant number CSIC-COV19-014, MCIU grant number PID2020-113888RB-I00, ISCIII grant number PI21/00139, and institutional grants to CBMSO from Fundación Ramón Areces and Banco Santander. D.B. (Denis Beslic) and K.K. were supported by the European Centers for Disease Control (grant number ECDC GRANT/2021/008 ECD.12222). D.B. (Dimitri Boeckaerts) was supported by the Research Foundation—Flanders (‘Fonds voor Wetenschappelijk Onderzoek—Vlaanderen’, 1S69520N). E.G.T. was supported by the Biotechnology and Biological Sciences Research Council (grant numbers BB/T015616, BB/T016256). E.B.H was funded by Swiss National Science Foundation (SNSF) grant number 31CA30 196046. D.J. is supported for his research on Fecal microbiota transplants in ulcerative colitis patients by the ‘Fonds Wetenschappelijk Onderzoek’ (Research foundation Flanders (1S78021N). A.L. was supported by the National Science Foundation award #1951678 and the Gordon and Betty Moore Foundation award GBMF9871. G.L.L. was funded by the Marie Skłodowska-Curie Actions Innovative Training Networks grant agreement number 955974 (VIROINF). P.L. was supported by the European Research Council under the European Union’s Horizon 2020 grant agreement number 725422-ReservoirDOCS, by Wellcome Trust project 206298/Z/17/Z (Artic Network), by the Research Foundation—Flanders (‘Fonds voor Wetenschappelijk Onderzoek—Vlaanderen’, G0D5117N and G051322N) and by NIH grant R01AI153044. L.N. was supported by the JSPS KAKENHI grant number JP 18H05506 and 21J22509. M.R. was funded by Studienstiftung des deutschen Volkes and DigLeben (Digitalisierung der Lebenswissenschaften—Wege in die Zukunft). F.W. was funded by the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) SFB 1021 (project number 197785619)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice

  • Pastor-Fernández, Andrés
  • Bertos, Antonio R
  • Sierra-Ramírez, Arantzazu
  • Del Moral-Salmoral, Javier
  • Merino, Javier
  • Ávila, Ana Isabel de
  • Olagüe, Cristina
  • Villares, Ricardo
  • González-Aseguinolaza, Gloria
  • Rodríguez, María Ángeles
  • Fresno, Manuel
  • Gironés, Nuria
  • Bustos, Matilde
  • Smerdou, Cristian
  • Fernández-Marcos, Pablo José
  • Von Kobbe, Cayetano
The enormous societal impact of the ongoing COVID-19 pandemic has been particularly harsh for some social groups, such as the elderly. Recently, it has been suggested that senescent cells could play a central role in pathogenesis by exacerbating the pro-inflammatory immune response against SARS-CoV-2. Therefore, the selective clearance of senescent cells by senolytic drugs may be useful as a therapy to ameliorate the symptoms of COVID-19 in some cases. Using the established COVID-19 murine model K18-hACE2, we demonstrated that a combination of the senolytics dasatinib and quercetin (D/Q) significantly reduced SARS-CoV-2-related mortality, delayed its onset, and reduced the number of other clinical symptoms. The increase in senescent markers that we detected in the lungs in response to SARS-CoV-2 may be related to the post-COVID-19 sequelae described to date. These results place senescent cells as central targets for the treatment of COVID-19, and make D/Q a new and promising therapeutic tool., This work was supported by grants from the Instituto de Salud Carlos III (ISCIII), COV20-00755 (C.V.K.) and COV20-00792 (M.B., M.A.R.), Apadrina la Ciencia (C.S., C.O., G.G.A.), the AECC Scientific Foundation, PRDMA18011PAST, SIRTBIO- LABAE18008FERN (P.J.F.M., A.P., A.S.R.), the RETOS projects Programme of Ministerio de Ciencia e Innovación (MICINN), SAF2017-85766-R and PID2020-114077RB-I00 (P.J.F.M., A.P., A.S.R.), Ramon y Cajal Award from MICINN, RYC-2017-22335 (P.J.F.M., A.P., A.S.R.), Proyecto REACT from REACT/European Union/FEDER, COVTRAVI-19-CM U (J.M.S., M.F., N.G.), grant from Consejo Superior de Investigaciones Científicas (CSIC), CSIC-COV19-014 (A.I.d.Á), PID2020-113888RB-I00 from MICINN (A.I.d.Á), and the European Commission–Next Generation EU (regulation EU 2020/2094), through the CSIC's Global Health Platform (PTI+ Global Health) (A.I.d.Á). The RT–qPCR reactions were provided by the Genomics and NGS Core Facility (GENGS) at the Centro de Biología Molecular Severo Ochoa (CBMSO, CSIC-UAM) Madrid, Spain, which obtains general funding from both institutions. The GENGS facility is part of the PTI+ Global Health (CSIC) (http://www.cbm.uam.es/genomica)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing

  • Llorens-Revull, Meritxell
  • Martínez-González, Brenda
  • Quer, Josep
  • Esteban, Juan Ignacio
  • Núñez-Moreno, Gonzalo
  • Mínguez, Pablo
  • Burgui, Idoia
  • Ramos-Ruiz, Ricardo
  • Soria, María Eugenia
  • Rico, Angie
  • Riveiro-Barciela, Mar
  • Sauleda, Silvia
  • Piron, María
  • Corrales, Irene
  • Borràs, Francesc E.
  • Rodríguez-Frías, Francisco
  • Rando, Ariadna
  • Ramírez-Serra, Clara
  • Camós, Silvia
  • Domingo, Esteban
  • Bes, Marta
  • Perales, Celia
  • Costafreda, María Isabel
MicroRNAs (miRNAs) encapsulated in extracellular vesicles (EVs) are potential diagnostic and prognostic biomarkers. However, discrepancies in miRNA patterns and their validation are still frequent due to differences in sample origin, EV isolation, and miRNA sequencing methods. The aim of the present study is to find a reliable EV isolation method for miRNA sequencing, adequate for clinical application. To this aim, two comparative studies were performed in parallel with the same human plasma sample: (i) isolation and characterization of EVs obtained using three procedures: size exclusion chromatography (SEC), iodixanol gradient (GRAD), and its combination (SEC+GRAD) and (ii) evaluation of the yield of miRNA sequences obtained using NextSeq 500 (Illumina) and three miRNA library preparation protocols: NEBNext, NEXTFlex, and SMARTer smRNA-seq. The conclusion of comparison (i) is that recovery of the largest amount of EVs and reproducibility were attained with SEC, but GRAD and SEC+GRAD yielded purer EV preparations. The conclusion of (ii) is that the NEBNext library showed the highest reproducibility in the number of miRNAs recovered and the highest diversity of miRNAs. These results render the combination of GRAD EV isolation and NEBNext library preparation for miRNA retrieval as adequate for clinical applications using plasma samples., This study was funded by Instituto de Salud Carlos III, co-financed by the European Regional Development Fund (ERDF): grant numbers PI18/00210, PI19/00301, PI19/00533, PI21/00139, and PI22/00258; Centro para el Desarrollo Tecnológico Industrial (CDTI) from the Spanish Ministry of Economy and Business, grant number IDI-20200297. The work at CBMSO was supported by grants SAF2014-52400-R from Ministerio de Economía y Competitividad (MINECO), SAF2017-87846-R and BFU2017-91384-EXP from Ministerio de Ciencia, Innovación y Universidades (MCIU), project 525/C/2021 from Fundaciό La Maratό de TV3, PID2020-113888RB-I00, PID2021-126447OB-I00, and 202220I116 from Ministerio de Ciencia e Innovaciόn (MICINN), S2013/ABI-2906 (PLATESA from Comunidad de Madrid/FEDER), and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). This research work was also funded by the European Commission–NextGenerationEU (regulation EU 2020/2094) through the CSIC’s Global Health Platform (PTI Salud Global). C.P. is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CP14/00121 and CPII19/00001), co-financed by the European Regional Development Fund (ERDF). M.LL. is a recipient of a pre-doctoral fellowship from Instituto de Salud Carlos III (FI20/00313), co-financed by the European Regional Development Fund (ERDF). B.M.-G. is supported by pre-doctoral contract PFIS FI19/00119 from ISCIII, co-financed by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro”. CIBERehd (Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas) is funded by ISCIII. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells

  • García-Crespo, Carlos
  • Francisco-Recuero, Irene
  • Gallego, Isabel
  • Camblor-Murube, Marina
  • Soria, María Eugenia
  • López-López, Ana
  • Ávila, Ana Isabel de
  • Madejón, Antonio
  • García-Samaniego, Javier
  • Domingo, Esteban
  • Sánchez-Pacheco, Aurora
  • Perales, Celia
[Introduction]: Cellular epigenetic modifications occur in the course of viral infections. We previously documented that hepatitis C virus (HCV) infection of human hepatoma Huh-7.5 cells results in a core protein-mediated decrease of Aurora kinase B (AURKB) activity and phosphorylation of Serine 10 in histone H3 (H3Ser10ph) levels, with an affectation of inflammatory pathways. The possible role of HCV fitness in infection-derived cellular epigenetic modifications is not known. [Methods]: Here we approach this question using HCV populations that display a 2.3-fold increase in general fitness (infectious progeny production), and up to 45-fold increase of the exponential phase of intracellular viral growth rate, relative to the parental HCV population. [Results]: We show that infection resulted in a HCV fitness-dependent, average decrease of the levels of H3Ser10ph, AURKB, and histone H4 tri-methylated at Lysine 20 (H4K20m3) in the infected cell population. Remarkably, the decrease of H4K20m3, which is a hallmark of cellular transformation, was significant upon infection with high fitness HCV but not upon infection with basal fitness virus. [Discussion]: Here we propose two mechanisms ─which are not mutually exclusive─ to explain the effect of high viral fitness: an early advance in the number of infected cells, or larger number of replicating RNA molecules per cell. The implications of introducing HCV fitness as an influence in virus-host interactions, and for the course of liver disease, are warranted. Emphasis is made in the possibility that HCV-mediated hepatocellular carcinoma may be favoured by prolonged HCV infection of a human liver, a situation in which viral fitness is likely to increase., The work at CBMSO was supported by grants SAF2014-52400-R from Ministerio de Economía y Competitividad (MINECO), SAF2017-87846-R, BFU2017-91384-EXP from Ministerio de Ciencia, Innovación y Universidades (MCIU), project 525/C/2021 from Fundació La Marató de TV3, PID2020-113888RB-I00 from Ministerio de Ciencia e Innovación, PI18/00210 and PI21/00139 from Instituto de Salud Carlos III, S2013/ABI-2906, (PLATESA from Comunidad de Madrid/FEDER) and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). This research work was also funded by the European Commission– NextGenerationEU (regulation EU 2020/2094), through the CSIC’s Global Health Platform (PTI Salud Global). CP is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CP14/00121 and CPII19/00001) cofinanced by the European Regional Development Fund (ERDF). CIBERehd (Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas) is funded by Instituto de Salud Carlos III. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). C. G.-C. is supported by predoctoral contract PRE2018-083422 from MCIU. The work at the UAM was supported by grant from Comunidad de Madrid IND2018/BMD9499. IF-R was supported by fellowships from Postgraduates studies from Universidad Autonoma de Madrid and from Ministerio de Educación Cultura y Deporte (MECD) FPU13/00945. The work at La Paz hospital was partially supported by grant PI12/02146 from “Fondo de Investigaciones Sanitarias”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Viruses as archaeological tools for uncovering ancient molecular relationships

  • Ariza-Mateos, Ascensión
  • Briones, Carlos
  • Perales, Celia
  • Bayo-Jiménez, María Teresa
  • Domingo, Esteban
  • Gómez-Castilla, Jordi
The entry of a virus into the host cell always implies the alteration of certain intracellular molecular relationships, some of which may involve the recovery of ancient cellular activities. In this sense, viruses are archaeological tools for identifying unexpressed activities in noninfected cells. Among these, activities that hinder virus propagation may represent cellular defense mechanisms, for example, activities that mutagenize the viral genome such as ADAR-1 or APOBEC activities. Instead, those that facilitate virus propagation can be interpreted as the result of viral adaptation to—or mimicking—cellular structures, enabling the virus to perform anthropomorphic activities, including hijacking, manipulating, and reorganizing cellular factors for their own benefit. The alternative we consider here is that some of these second set of cellular activities were already in the uninfected cell but silenced, under the negative control of the cell or lineage, and that they represent a necessary precondition for viral infection. For example, specifically loading an amino acid at the 3'-end of the mRNA of some plant viruses by aminoacyl-tRNA synthetases has proved essential for virus infection despite this reaction not occurring with cellular mRNAs. Other activities of this type are discussed here, together with the biological context in which they acquire a coherent meaning, that is, genetic latency and molecular conflict., This work has been funded by Ministerio de Ciencia e Innovacion, Agencia Estatal de Investigacion “PROYECTOS DE I+D+i” PID2020-113888RB-I00 to E.D. and J.G., and PID2019-104903RB-I00 to C.B. We thank LifeHUB.CSIC initiative (PIE 202120E047-CONEXIONES-LIFE) for the interesting discussions held in the forum., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Natural languages and RNA virus evolution

  • Ariza-Mateos, Ascensión
  • Briones, Carlos
  • Perales, Celia
  • Sobrino Castelló, Francisco
  • Gómez-Castilla, Jordi
Information concepts from physics, mathematics and computer science support many areas of research in biology. Their focus is on objective information, which provides correlations and patterns related to objects, processes, marks and signals. In these approaches only the quantitative aspects of the meaning of the information is relevant. In other areas of biology, ‘meaningful information’, which is subjective in nature, relies on the physiology of the organism's sensory organs and on the interpretation of the perceived signals, which is then translated into action, even if this is only mental (in brained animals). Information is involved, in terms of both amount and quality. Here we contextualize and review the main theories that deal with ‘meaningful-information’ at a molecular level from different areas of natural language research, namely biosemiotics, code-biology, biocommunication and biohermeneutics. As this information mediates between the organism and its environment, we emphasize how such theories compare with the neo-Darwinian treatment of genetic information, and how they project onto the rapid evolution of RNA viruses., This work was funded by: Ministerio de Ciencia e Innovacion (MICINN), Agencia Estatal de Investigacion(AEI) «PROYECTOS DE I+D+i» PID2020-113888RB-I00to E.D. and J.G., and PID2019-104903RB-I00 to C.B.We also benefit from the interdisciplinary frameworkprovided by CSIC through the ‘LifeHUB.CSIC’ initiative(PIE 202120E047-Conexiones-Life). We thank Jaime Lechugafor his help in designing Fig. 2., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Archaeological approaches to RNA virus evolution

  • Ariza-Mateos, Ascensión
  • Briones, Carlos
  • Perales, Celia
  • Sobrino Castelló, Francisco
  • Domingo, Esteban
  • Gómez-Castilla, Jordi
Studies with RNA enzymes (ribozymes) and protein enzymes have identified certain structural elements that are present in some cellular mRNAs and viral RNAs. These elements do not share a primary structure and, thus, are not phylogenetically related. However, they have common (secondary/tertiary) structural folds that, according to some lines of evidence, may have an ancient and common origin. The term ‘mRNA archaeology’ has been coined to refer to the search for such structural/functional relics that may be informative of early evolutionary developments in the cellular and viral worlds and have lasted to the present day. Such identified RNA elements may have developed as biological signals with structural and functional relevance (as if they were buried objects with archaeological value), and coexist with the standard linear information of nucleic acid molecules that is translated into proteins. However, there is a key difference between the methods that extract information from either the primary structure of mRNA or the signals provided by secondary and tertiary structures. The former (sequence comparison and phylogenetic analysis) requires strict continuity of the material vehicle of information during evolution, whereas the archaeological method does not require such continuity. The tools of RNA archaeology (including the use of ribozymes and enzymes to investigate the reactivity of the RNA elements) establish links between the concepts of communication and language theories that have not been incorporated into knowledge of virology, as well as experimental studies on the search for functionally relevant RNA structures., This work has been funded by: Ministerio de Ciencia eInnovacion (MICINN), Agencia Estatal de Investigacion (AEI)«PROYECTOS DE I+D+i» PID2020-113888RB-I00 to E.D.and J.G., and PID2019-104903RB-I00 to C.B. We acknowledge the interdisciplinary framework provided byConsejo Superior de Investigaciones Científicas (CSIC) through‘LifeHUB.CSIC’ initiative (PIE 202120E047-Conexiones-Life)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Application of archaeological concepts to the interpretation of RNA virus quasi species evolution

  • Ariza-Mateos, Ascensión
  • Perales, Celia
  • Domingo, Esteban
  • Gómez-Castilla, Jordi
An enduring problem concerning the evolution of RNA viruses stems from the fact that their long-term rates of evolution (substitutions/ site/year) are lower than those calculated by comparing sequences of isolates collected over short time periods or within a single host (shortterm or intra-host evolution). This inconsistency has been attributed to several reasons, including deviations from the assumption of a molecularclock (constancy of mutational inputs as a function of time) and variations in viral multiplication rates, among others. We previously proposed a non-phylogenetic method for extracting information contained in mRNAs, that cannot be identified from examination of primary sequences alone, and that we called «archaeological» information. In this new approach, mRNAs are of interest as molecules, not for their primary sequence or encoded proteins but for encrypted information established in a remote past. In the present article, we propose that an archaeological approach may also contribute to explain higher short-term than long-term evolution rates in RNA viruses, in this case, by using the archaeological concept of palimpsest. The palimpsest is a record of historical changes, but it is not a successively ordered or a complete record, rather it is the product of two opposing activities, one of writing and rewriting and the other of erasing. In RNA virus quasispecies, the gain or loss of mutations is reflected in changes in the submolar frequency of myriads of variants in the population. The fact that mutation elimination is not always complete, turns viral quasispecies into complex palimpsests of viral variants or sub-populations thereof. Here we relate two main different temporalities of the quasispecies palimpsest (short- and long-term) to the stability of mutations in response to changes related to three components of the virus: the virions, the infected cell and the host cell lineage. Host cell lineage-related viral memory would be mostly irre versible as they are adaptive products to host cell changes. In contrast, memories related to the environment of the virion or responsive to the environment of the infected cell, which is shortterm mutational input, is less constrained provided the alteration in the ancestral information carried by the RNA is only transient. The two intermixed memory components result in two differently contributing mutation rates whose influence in the final result depends on whether the timescales used to take the sequences for comparison are short or long term., This work has been funded by: Ministerio de Ciencia e Innovacion, Agencia Estatal de Investigacion «PROYECTOS DE I+D+i» PID2020-113888RB-I00 to ED and JG. And by Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas CIBERehd (Instituto de Salud Carlos III)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin

  • Somovilla, Pilar
  • García-Crespo, Carlos
  • Martínez-González, Brenda
  • Soria, María Eugenia
  • Ávila, Ana Isabel de
  • Gallego, Isabel
  • Mínguez, Pablo
  • Durán-Pastor, Antoni
  • Ferrer-Orta, Cristina
  • Salar-Vidal, Llanos
  • Esteban-Muñoz, Mario
  • Zúñiga Lucas, Sonia
  • Solá Gurpegui, Isabel
  • Enjuanes Sánchez, Luis
  • Esteban, Jaime
  • Fernández-Roblas, Ricardo
  • Gadea, Ignacio
  • Gómez-Castilla, Jordi
  • Verdaguer, Núria
  • Domingo, Esteban
  • Perales, Celia
We report that ribavirin exerts an inhibitory and mutagenic activity on SARS-CoV-2-infecting Vero cells, with a therapeutic index higher than 10. Deep sequencing analysis of the mutant spectrum of SARS-CoV-2 replicating in the absence or presence of ribavirin indicated an increase in the number of mutations, but not in deletions, and modification of diversity indices, expected from a mutagenic activity. Notably, the major mutation types enhanced by replication in the presence of ribavirin were A→G and U→C transitions, a pattern which is opposite to the dominance of G→A and C→U transitions previously described for most RNA viruses. Implications of the inhibitory activity of ribavirin, and the atypical mutational bias produced on SARS-CoV-2, for the search for synergistic anti-COVID-19 lethal mutagen combinations are discussed., This work was supported by Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (COVID-19 Research Call COV20/00181) and cofinanced by the European Development Regional Fund, “A way to achieve Europe.” The work was also supported by grants CSIC-COV19-014 from Consejo Superior de Investigaciones Científicas (CSIC), project 525/C/2021 from Fundació La Marató de TV3, PID2020-113888RB-I00 and 202220I116 from Ministerio de Ciencia e Innovación, BFU2017-91384-EXP from Ministerio de Ciencia, Innovación y Universidades (MCIU), PI18/00210 and PI21/00139 from Instituto de Salud Carlos III, and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). This research work was also funded by the European Commission-NextGenerationEU (regulation EU 2020/2024) through the CSIC’s Global Health Platform (PTI Salud Global). C.P. is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CP14/00121 and CPII19/00001), cofinanced by the European Regional Development Fund (ERDF). CIBERehd (Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas) is funded by Instituto de Salud Carlos III. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). C.G.-C. is supported by predoctoral contract PRE2018-083422 from MCIU. P.S. is supported by postdoctoral contract Margarita Salas, CA1/RSUE/2021 from MCIU. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from ISCIII, cofinanced by Fondo Social Europeo (FSE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fitness-Dependent, Mild Mutagenic Activity of Sofosbuvir for Hepatitis C Virus

  • Martínez-González, Brenda
  • Gallego, Isabel
  • Gregori, Josep
  • Soria, María Eugenia
  • Somovilla, Pilar
  • Ávila, Ana Isabel de
  • García-Crespo, Carlos
  • Durán-Pastor, Antoni
  • Briones, Carlos
  • Gómez, Jordi
  • Quer, Josep
  • Domingo, Esteban
  • Perales, Celia
The concept of a mild mutagen was coined to describe a minor mutagenic activity exhibited by some nucleoside analogues that potentiated their efficacy as antiretroviral agents. In the present study, we report the mild mutagen activity of sofosbuvir (SOF) for hepatitis C virus (HCV). Serial passages of HCV in human hepatoma cells, in the presence of SOF at a concentration well below its cytotoxic concentration 50 (CC) led to pre-extinction populations whose mutant spectra exhibited a significant increase of C!U transitions, relative to populations passaged in the absence of SOF. This was reflected in an increase in several diversity indices that were used to characterize viral quasispecies. The mild mutagenic activity of SOF was largely absent when it was tested with isogenic HCV populations that displayed high replicative fitness. Thus, SOF can act as a mild mutagen for HCV, depending on HCV fitness. Possible mechanisms by which the SOF mutagenic activity may contribute to its antiviral efficacy are discussed., The work at CBMSO was supported by grants SAF2014-52400-R from Ministerio de Economía y Competitividad (MINECO); SAF2017-87846-R and BFU2017-91384-EXP from Ministerio de Ciencia, Innovación y Universidades (MCIU); project 525/C/2021 from Fundació La Marató de TV3; PID2020-113888RB-I00 and 202220I116 from Ministerio de Ciencia e Innovación (MICINN); PI18/00210, PI19/00301, PI21/00139, and PI22/00258 from Instituto de Salud Carlos III (ISCIII); S2013/ABI-2906 (PLATESA from Comunidad de Madrid/FEDER); and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). This research work was also funded by the European Commission-NextGenerationEU (regulation EU 2020/ 2094) through the CSIC’s Global Health Platform (PTI Salud Global). C.P. is supported by the Miguel Servet program of the ISCIII (CP14/00121 and CPII19/00001), cofinanced by the European Regional Development Fund (ERDF). B.M.-G. is supported by the predoctoral contract PFIS FI19/00119 from ISCIII, cofinanced by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro”. C.G.-C. is supported by the predoctoral contract PRE2018-083422 from MCIU. P.S. is supported by the postdoctoral contract Margarita Salas, CA1/RSUE/ 2021 from MCIU. A.D.-P. is supported by the contract 13-2022-008566 cofinanced by the Comunidad de Madrid, through the Programa Investigo, en el marco del Plan de Recuperación, Transformación y Resiliencia, financed by the European Union-Next Generation EU. CIBERehd (Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas), which is funded by ISCIII. The work at CAB was supported by the MICINN grant no. PID2019-104903RB-I00. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies

  • Domingo, Esteban
  • Martínez-González, Brenda
  • García-Crespo, Carlos
  • Somovilla, Pilar
  • Ávila, Ana Isabel de
  • Soria, María Eugenia
  • Durán-Pastor, Antoni
  • Perales, Celia
Upon the emergence of SARS-CoV-2 in the human population, it was conjectured that for this coronavirus the dynamic intra-host heterogeneity typical of RNA viruses would be toned down. Nothing of this sort is observed. Here we review the main observations on the complexity and diverse composition of SARS-CoV-2 mutant spectra sampled from infected patients, within the framework of quasispecies dynamics. The analyses suggest that the information provided by myriads of genomic sequences within infected individuals may have a predictive value of the genomic sequences that acquire epidemiological relevance. Possibilities to reconcile the presence of broad mutant spectra in the large RNA coronavirus genome with its encoding a 3' to 5' exonuclease proofreading-repair activity are considered. Indeterminations in the behavior of individual viral genomes provide a benefit for the survival of the ensemble. We propose that this concept falls in the domain of "stochastic thinking," a notion that applies also to cellular processes, as a means for biological systems to face unexpected needs., The work was supported by the Ministerio de Ciencia e Innovación, grants PID2020-113888RB-I00 and 202220I116, and by the European Commission-Next Generation EU (regulation EU 2020/2024) through the CSIC’s Global Health Platform (PTI Salud Global). The work was also funded by grants PI21/00139 from Instituto de Salud Carlos III, CSIC-COV19-014 from Consejo Superior de Investigaciones Científicas (CSIC) and project 525 /C/2021 from Fundació La Marató de TV3, grants 202136–30 and 202136–31. We also acknowledge the project S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III cofinanced by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro.” C.G.-C. is supported by predoctoral contract PRE2018-083422 from Ministerio de Ciencia, Innovación y Universidades (MCIU). P.S. is supported by postdoctoral contract Margarita Salas, CA1/RSUE/2021 from MCIU. A.D.-P. is supported by the contract 13–2022-008566 cofinanced by the Comunidad de Madrid, through the Programa Investigo, en el marco del Plan de Recuperación, Transformación y Resiliencia, financed by the European Union—Next Generation EU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Reply to Qu et al., “Quasispecies are constantly selected through virus-encoded intracellular reproductive population bottlenecking”

  • Domingo, Esteban
  • Martínez-González, Brenda
  • García-Crespo, Carlos
  • Somovilla, Pilar
  • Ávila, Ana Isabel de
  • Soria, María Eugenia
  • Durán-Pastor, Antoni
  • Perales, Celia
We appreciate the careful reading by F. Qu, K. Khemsom, C. Perdoncini Carvalho, and J. Han of our minireview on SARS-CoV-2 quasispecies recently published in the Journal of Virology (1). Qu and colleagues disagree with one of our assertions about viral quasispecies in general, namely that the mutant genome copies generated during viral RNA replication can collectively engage in evolution. Their main argument is that when a viral population enters a cell, it becomes strongly bottlenecked, and only one or a few of the viruses have a chance to replicate. The remaining copies are degraded, although they may contribute to the cellular modifications required for the formation of replication organelles. An advantage of such bottlenecking for virus survival is that genomes that, during prior replication, mutated to encode a different phenotype find an unchallenged cellular environment to feely multiply and express the deviant phenotype. This model is termed “Bottleneck, Isolate, Amplify, Select” (BIAS), and it is presented as contrary to the premise of quasispecies theory because “the BIAS model is unapologetically deterministic and predicts natural selection as the primary driver of virus evolution.”, Ministerio de Ciencia e Innovación (MCIN) PID2020-113888RB-I00 Esteban Domingo Ministerio de Ciencia e Innovación (MCIN) 202220I116 Celia Perales MEC | Instituto de Salud Carlos III (ISCIII) PI21/00139 Celia Perales MEC | Consejo Superior de Investigaciones Científicas (CSIC) CSIC-COV19-014 Esteban Domingo Fundació La Marató 525/C/2021 Celia Perales Comunidad de Madrid (Community of Madrid) S2018/BAA-4370 Esteban Domingo MEC | Instituto de Salud Carlos III (ISCIII) FI19/00119 Brenda MartínezGonzález Ministerio de Ciencia, Innovación y Universidades (MCIU) PRE2018-083422 Carlos GarcíaCrespo Ministerio de Ciencia, Innovación y Universidades (MCIU) CA1/RSUE/2021 Pilar Somovilla Comunidad de Madrid (Community of Madrid) 13-2022-008566 Antoni Durán-Pastor, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synergism between remdesivir and ribavirin leads to SARS-CoV-2 extinction in cell culture

  • García-Crespo, Carlos
  • Ávila, Ana Isabel de
  • Gallego, Isabel
  • Soria, María Eugenia
  • Durán-Pastor, Antoni
  • Somovilla, Pilar
  • Martínez-González, Brenda
  • Muñoz-Flores, Javier
  • Mínguez, Pablo
  • Salar-Vidal, Llanos
  • Esteban-Muñoz, Mario
  • Cañar-Camacho, Elizabeth
  • Ferrer-Orta, Cristina
  • Zúñiga Lucas, Sonia
  • Solá Gurpegui, Isabel
  • Enjuanes Sánchez, Luis
  • Esteban, Jaime
  • Fernández-Roblas, Ricardo
  • Gadea, Ignacio
  • Gómez, Jordi
  • Verdaguer, Núria
  • Domingo, Esteban
  • Perales, Celia
[Background and Purpose] There is a need for effective anti-COVID-19 treatments, mainly for individuals at risk of severe disease such as the elderly and the immunosuppressed. Drug repositioning has proved effective in identifying drugs that can find a new application for the control of coronavirus disease, in particular COVID-19. The purpose of the present study was to find synergistic antiviral combinations for COVID-19 based on lethal mutagenesis., [Experimental Approach] The effect of combinations of remdesivir and ribavirin on the infectivity of SARS-CoV-2 in cell culture has been tested. Viral populations were monitored by ultra-deep sequencing, and the decrease of infectivity as a result of the treatment was measured., [Key Results] Remdesivir and ribavirin exerted a synergistic inhibitory activity against SARS-CoV-2, quantified both by CompuSyn (Chou-Talalay method) and Synergy Finder (ZIP-score model). In serial passage experiments, virus extinction was readily achieved with remdesivir-ribavirin combinations at concentrations well below their cytotoxic 50 value, but not with the drugs used individually. Deep sequencing of treated viral populations showed that remdesivir, ribavirin, and their combinations evoked significant increases of the number of viral mutations and haplotypes, as well as modification of diversity indices that characterize viral quasi-species., [Conclusion and Implications] SARS-CoV-2 extinction can be achieved by synergistic combination treatments based on lethal mutagenesis. In addition, the results offer prospects of triple drug treatments for effective SARS-CoV-2 suppression., The work was supported by the Span- ish Ministry of Science and Innovation, grants PID2020-117976GB- I00, PID2020-113888RB-I00/AEI/10.13039/501100011033 and 202220I116 and by the European Commission-Next Generation EU (regulation EU 2020/2024) through the CSIC's Global Health Platform (PTI Salud Global). The work was also funded by grants PI21/00139 from Instituto de Salud Carlos III co-funded by the European Union, CSIC-COV19-014 from Consejo Superior de Investigaciones Científicas (CSIC) and project 525/C/2021 from Fundacio La Marato de TV3, grants 202136-30 and 202136-31. We also acknowledge the project S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). C.G.-C. is supported by predoctoral contract PRE2018-083422 from MCIU. A.D-P. is sup- ported by the contract 13-2022-008566 co-financed by the Comunidad de Madrid, through the Programa Investigo, en el marco del Plan de Recuperación, Transformación y Resiliencia, financed by the European Union - Next Generation EU. P.S. is supported by postdoc- toral contract Margarita Salas, CA1/RSUE/2021 from MCIU. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III co-financed by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro.” P.M. is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CPII21/00015), co-financed by the European Regional Development Fund (ERDF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 mutant spectra as variant of concern nurseries: endless variation?

  • Martínez-González, Brenda
  • Soria, María Eugenia
  • Mínguez, Pablo
  • Lorenzo-Redondo, Ramón
  • Salar-Vidal, Llanos
  • López-García, Alberto
  • Esteban-Muñoz, Mario
  • Durán-Pastor, Antoni
  • Somovilla, Pilar
  • García-Crespo, Carlos
  • Ávila, Ana Isabel de
  • Gómez, Jordi
  • Esteban, Jaime
  • Fernández-Roblas, Ricardo
  • Gadea, Ignacio
  • Domingo, Esteban
  • Perales, Celia
[Introduction] SARS-CoV-2 isolates of a given clade may contain low frequency genomes that encode amino acids or deletions which are typical of a different clade., [Methods] Here we use high resolution ultra-deep sequencing to analyze SARS-CoV-2 mutant spectra., [Results] In 6 out of 11 SARS-CoV-2 isolates from COVID-19 patients, the mutant spectrum of the spike (S)-coding region included two or more amino acids or deletions, that correspond to discordant viral clades. A similar observation is reported for laboratory populations of SARS-CoV-2 USA-WA1/2020, following a cell culture infection in the presence of remdesivir, ribavirin or their combinations. Moreover, some of the clade-discordant genome residues are found in the same haplotype within an amplicon., [Discussion] We evaluate possible interpretations of these findings, and reviewed precedents for rapid selection of genomes with multiple mutations in RNA viruses. These considerations suggest that intra-host evolution may be sufficient to generate minority sequences which are closely related to sequences typical of other clades. The results provide a model for the origin of variants of concern during epidemic spread─in particular Omicron lineages─that does not require prolonged infection, involvement of immunocompromised individuals, or participation of intermediate, non-human hosts., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The study was supported by the Spanish Ministry of Science and Innovation, grants PID2020-113888RB-I00/AEI/10.13039/501100011033 and 202220 I116 and by the European Commission-Next Generation EU (regulation EU 2020/2024) through the CSIC’s Global Health Platform (PTI Salud Global). The work was also funded by grants PI21/00139 funding from Instituto de Salud Carlos III (ISCIII), co-funded by the European Union, CSIC-COV19-014 from Consejo Superior de Investigaciones Científicas (CSIC) and project 525/C/2021 from Fundació La Marató de TV3, grants 202136-30 and 202136-31. We also acknowledge the project S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). BM-G is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III cofinanced by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro.” PM is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CPII21/00015), cofinanced by the European Regional Development Fund (ERDF). AD-P is supported by the contract 13-2022-008566 cofinanced by the Comunidad de Madrid, through the Programa Investigo, en el marco del Plan de Recuperación, Transformación y Resiliencia, financed by the European Union - Next Generation EU. PS is supported by postdoctoral contract Margarita Salas, CA1/ RSUE/2021 from MCIU. CG-C is supported by predoctoral contract PRE2018-083422 from MCIU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps

  • Delgado, Soledad
  • Somovilla, Pilar
  • Ferrer-Orta, Cristina
  • Martínez-González, Brenda
  • Vázquez-Monteagudo, Sergi
  • Muñoz-Flores, Javier
  • Soria, María Eugenia
  • García-Crespo, Carlos
  • Ávila, Ana Isabel de
  • Durán-Pastor, Antoni
  • Gadea, Ignacio
  • López-Galíndez, Cecilio
  • Morán, Federico
  • Lorenzo-Redondo, Ramón
  • Verdaguer, Núria
  • Perales, Celia
  • Domingo, Esteban
Since its introduction in the human population, SARS-CoV-2 has evolved into multiple clades, but the events in its intrahost diversification are not well understood. Here, we compare three-dimensional (3D) self-organized neural haplotype maps (SOMs) of SARS-CoV-2 from thirty individual nasopharyngeal diagnostic samples obtained within a 19-day interval in Madrid (Spain), at the time of transition between clades 19 and 20. SOMs have been trained with the haplotype repertoire present in the mutant spectra of the nsp12- and spike (S)-coding regions. Each SOM consisted of a dominant neuron (displaying the maximum frequency), surrounded by a low-frequency neuron cloud. The sequence of the master (dominant) neuron was either identical to that of the reference Wuhan-Hu-1 genome or differed from it at one nucleotide position. Six different deviant haplotype sequences were identified among the master neurons. Some of the substitutions in the neural clouds affected critical sites of the nsp12-nsp8-nsp7 polymerase complex and resulted in altered kinetics of RNA synthesis in an in vitro primer extension assay. Thus, the analysis has identified mutations that are relevant to modification of viral RNA synthesis, present in the mutant clouds of SARS-CoV-2 quasispecies. These mutations most likely occurred during intrahost diversification in several COVID-19 patients, during an initial stage of the pandemic, and within a brief time period., Institutional support from Global Management Solutions and valuable discussions are acknowledged. The work at UPM was supported by grants PID2019-104903RB-100 and PID2022-139908OB-I00, funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe. The work at FJD was supported by project PI21/00139 from Instituto de Salud Carlos III, co-funded by the European Union. The work at CSIC was supported by PID2020-113888RB-I00, PID2020-117976GB-I00, and 202220I116 from Ministerio de Ciencia e Innovación and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). This research work was also funded by the European Commission – NextGenerationEU (regulation EU 2020/2094), through the CSIC’s Global Health Platform (PTI Salud Global), and Fundació La Marató de TV3 (project 525/C/2021), grants 202136-30 and 202136-31. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). Work at Centro Nacional de Microbiología (ISCIII) was supported by grants SAF2016-77894-R from MINECO and PI13/02269 from ISCIII. The work at Universidad Complutense Madrid has been supported by research grant CTQ2017-87864-C2-2-P, from MINECO. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from ISCIII, cofinanced by Fondo Social Europeo (FSE). A.D.-P. is supported by the contract 13-2022-008566 cofinanced by the Comunidad de Madrid, through the Programa Investigo, en el marco del Plan de Recuperación, Transformación y Resiliencia, financed by the European Union–Next Generation EU. P.S. is supported by postdoctoral contract “Margarita Salas” CA1/RSUE/2021 from MCIU. C.G.-C. is supported by predoctoral contract PRE2018-083422 from MCIU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Adapting the rhizome concept to an extended definition of viral quasispecies and the implications for molecular evolution

  • Raico Landa, Carlos
  • Ariza-Mateos, Ascensión
  • Briones, Carlos
  • Perales, Celia
  • Wagner, Astrid
  • Domingo, Esteban
  • Gómez, Jordi
The rhizome concept proposed by Gilles Deleuze and Félix Guattari offers a novel perspective on the organization and interdependence of complex constellations of heterogeneous entities, their mapping and their ruptures. The emphasis of the present study is placed on the dynamics of contacts and communication among such entities that arise from experimentation, without any favored hierarchy or origin. When applied to biological evolution, the rhizome concept integrates all types of heterogeneity resulting from “symbiotic” relationships among living beings (or their genomic material), horizontal genetic transfer, recombination and mutation, and breaks away from the approach that gives rise to the phylogenetic tree of life. It has already been applied to describe the dynamics and evolution of RNA viruses. Thus, here we introduce a novel framework for the interpretation the viral quasispecies concept, which explains the evolution of RNA virus populations as the result of dynamic interconnections and multifaceted interdependence between highly heterogeneous viral sequences and its inherently heterogeneous host cells. The rhizome network perspective underlines even further the medical implications of the broad mutant spectra of viruses that are in constant flow, given the multiple pathways they have available for fitness loss and gain., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature., This work was funded by: Ministerio de Ciencia e Innovacion (MICINN), Agencia Estatal de Investigacion (AEI) «PROYECTOS DE I+D+i» PID2020-113888RB-I00/AEI/https://doi.org/10.13039/501100011033 to E.D. and J.G., PID2019-104903RB-I00 and PID2022-139908OB-I00 to C.B, PID2020-117219GB-I00 to AW, and 202220I116 to C.P. The work was also funded by grants PI21/00139 from Instituto de Salud Carlos III, CSIC-COV19-014 from Consejo Superior de Investigaciones Científicas (CSIC) and project 525/C/2021 from Fundació La Marató de TV3, grants 202136-30 and 202136-31. We also benefit from the interdisciplinary framework provided by CSIC through the ‘LifeHUB.CSIC’ initiative (PIE 202120E047-Conexiones-Life). Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Point mutations at specific sites of the nsp12-nsp8 interface dramatically affect the RNA polymerization activity of SARS-CoV-2

  • Ferrer-Orta, Cristina
  • Vázquez-Monteagudo, Sergi
  • Ferrero, Diego
  • Martínez-González, Brenda
  • Perales, Celia
  • Domingo, Esteban
  • Verdaguer, Núria
In a recent characterization of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variability present in 30 diagnostic samples from patients of the first COVID-19 pandemic wave, 41 amino acid substitutions were documented in the RNA-dependent RNA polymerase (RdRp) nsp12. Eight substitutions were selected in this work to determine whether they had an impact on the RdRp activity of the SARS-CoV-2 nsp12-nsp8-nsp7 replication complex. Three of these substitutions were found around the polymerase central cavity, in the template entry channel (D499G and M668V), and within the motif B (V560A), and they showed polymerization rates similar to the wild type RdRp. The remaining five mutations (P323L, L372F, L372P, V373A, and L527H) were placed near the nsp12-nsp8F contact surface; residues L372, V373, and L527 participated in a large hydrophobic cluster involving contacts between two helices in the nsp12 fingers and the long α-helix of nsp8F. The presence of any of these five amino acid substitutions resulted in important alterations in the RNA polymerization activity. Comparative primer elongation assays showed different behavior depending on the hydrophobicity of their side chains. The substitution of L by the bulkier F side chain at position 372 slightly promoted RdRp activity. However, this activity was dramatically reduced with the L372P, and L527H mutations, and to a lesser extent with V373A, all of which weaken the hydrophobic interactions within the cluster. Additional mutations, specifically designed to disrupt the nsp12-nsp8F interactions (nsp12-V330S, nsp12-V341S, and nsp8-R111A/D112A), also resulted in an impaired RdRp activity, further illustrating the importance of this contact interface in the regulation of RNA synthesis., This work was funded by the Spanish Ministry of Science and Innovation, grants PID2020-117976GB-I00, PID2020-113888RB-I00/AEI/10.13039/501100011033, and 202220I116 and by the European Commission-Next Generation EU (regulation EU 2020/2024) through the CSIC’s Global Health Platform (PTI Salud Global). The grants PI21/00139 from Instituto de Salud Carlos III cofunded by the European Union, S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER), CSIC-COV19-014 from CSIC and from Fundació La Marató de TV3, grants 202136-30 and 202136-31, also support this work. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III cofinanced by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro.”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Quasispecies theory and emerging viruses: challenges and applications

  • Sardanyés, Josep
  • Perales, Celia
  • Domingo, Esteban
  • Elena, Santiago F.
Quasispecies theory revolutionized our understanding of viral evolution by describing viruses as dynamic populations of genetically diverse variants constantly adapting. This article explores the theory’s role in virus-host interactions, including immune evasion, drug resistance, and viral emergence. We review the original model, recent advances, and key virus dynamics needing incorporation into quasispecies theory. We introduce the ultracube concept as a more realistic multidimensional sequence space to investigate virus evolutionary dynamics., JS has been supported by grant PID2021-127896OB-I00 from MCIN/AEI/10.13039/501100011033“ERDF A way of making Europe” and from the María de Maeztu Program for Units of Excellence in R&D grant CEX2020-001084-M. JS also thanks the Generalitat de Catalunya CERCA Program for institutional support. ED and CP have been supported by grant PID2020-113888RB-I00 from MCIN/AEI/10.13039/501100011033 and 202220I116 and by the European Commission-Next Generation EU (regulation EU 2020/2024) through the CSIC Global Health Platform (PTI Salud Global); by grants PI21/00139 from Instituto de Salud Carlos III, and project 525/C/2021 from Fundació “La Marató de TV3”, grants 202136-30 and 202136-31. ED and CP also acknowledge the project S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER) and Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). SFE has been supported by grant PID2022-136912NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by“ERDF a way of making Europe”, and by grant CIPROM/2022/59 funded by Generalitat Valenciana., With funding from the Spanish government through the "Unit of Excellence Maria de Maeztu" accreditation (CEX2020-001084-M)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A general and biomedical perspective of viral quasispecies, Viral quasispecies

  • Domingo, Esteban
  • Martínez-González, Brenda
  • Somovilla, Pilar
  • García-Crespo, Carlos
  • Soria, María Eugenia
  • de Ávila, Ana Isabel
  • Gadea, Ignacio
  • Perales, Celia
Viral quasispecies refers to the complex and dynamic mutant distributions (also termed mutant spectra, clouds or swarms) that arise as a result of high error rates during RNA genome replication. The mutant spectrum of individual RNA virus populations is modified by continuous generation of variant genomes, competition and interactions among them, environmental influences, bottleneck events, and bloc transmission of viral particles. Quasispecies dynamics provides a new perspective on how viruses adapt, evolve and cause disease, and sheds light on strategies to combat them. Molecular flexibility, together with ample opportunity of mutant cloud traffic in our global world, are key ingredients of viral disease emergences, as exemplified by the recent COVID-19 pandemic. In the present article we present a brief overview of the molecular basis of mutant swarm formation and dynamics, and how the latter relates to viral disease and epidemic spread. We outline future challenges derived of the highly diverse cellular world in which viruses are necessarily installed., The work was supported by the Ministerio de Ciencia e Innovación, grants PID2020-113888RB-I00/AEI/10.13039/501100011033 and 202220I116, by the Ministerio de Ciencia, Innovación y Universidades (MICIU), grant PID2023-146622OB I00 financed by MICIU/AEI/10.13039/501100011033 and by FEDER, UE, through the “Severo Ochoa” Programmes for Centres of Excellence in R&D [CEX2021-001154-S and CEX2023-001386-S]. The work was also supported by the European Commission- Next Generation EU (regulation EU 2020/2024) through the CSIC’s Global Health Platform (PTI Salud Global). The work was also funded by grants PI21/00139 funding from Instituto de Salud Carlos III (ISCIII), co-funded by the European Union, CSIC COV19-014 from Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) and project 525/C/2021 from Fundació La Marató de TV3, grants 202136-30 and 202136-31. We also acknowledge the project S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN), and to the Biomedicine Unit of Universidad de Castilla La Mancha (UCLM), associated with CSIC. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III cofinanced by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro”. P.S. is supported by postdoctoral contract Margarita Salas, CA1/RSUE/2021 from MCIU. C.G.-C. was supported by predoctoral contract PRE2018-083422 from MCIU, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues

  • Ávila, Ana Isabel de
  • Soria, María Eugenia
  • Martínez-González, Brenda
  • Somovilla, Pilar
  • Mínguez, Pablo
  • Salar-Vidal, Llanos
  • Esteban-Muñoz, Mario
  • Martín-García, Marta
  • Zuñiga, Sonia
  • Solá Gurpegui, Isabel
  • Enjuanes Sánchez, Luis
  • Gadea, Ignacio
  • Perales, Celia
  • Domingo, Esteban
Defective genomes are part of SARS-CoV-2 quasispecies. High-resolution, ultra-deep sequencing of bulk RNA from viral populations does not distinguish RNA mutations, insertions, and deletions in viable genomes from those in defective genomes. To quantify SARS-CoV-2 infectious variant progeny, virus from four individual plaques (biological clones) of a preparation of isolate USA-WA1/2020, formed on Vero E6 cell monolayers, was subjected to further biological cloning to yield 9 second-generation and 15 third-generation sub-clones. Consensus genomic sequences of the biological clones and sub-clones included an average of 2.8 variations per viable genome, relative to the consensus sequence of the parental USA-WA1/2020 virus. This value is 6.5-fold lower than the estimates for biological clones of other RNA viruses such as bacteriophage Qβ, foot-and-mouth disease virus, or hepatitis C virus in cell culture. The mutant spectrum complexity of the nsp12 (polymerase)- and spike (S)-coding region was unique in the progeny of each of 10 third-generation sub-clones; they shared 2.4% of the total of 164 different mutations and deletions scored in the 3,719 genomic residues that were screened. The presence of minority out-of-frame deletions revealed the ease of defective genome production from an individual infectious genome. Several low-frequency point mutations and deletions were clade-discordant in that they were not typical of USA-WA1/2020 but served to define the consensus sequences of future SARS-CoV-2 clades. Implications for SARS-CoV-2 adaptability and COVID-19 control of the viable genome heterogeneity and the generation of complex mutant spectra from individual genomes are discussed.IMPORTANCESequencing of biological clones is a means to identify mutations, insertions, and deletions located in viable genomes. This distinction is particularly important for viral populations, such as those of SARS-CoV-2, that contain large proportions of defective genomes. By sequencing biological clones and sub-clones, we quantified the heterogeneity of the viable complement of USA-WA1/2020 to be lower than exhibited by other RNA viruses. This difference may be due to a reduced mutation rate or to limited tolerance of the large coronavirus genome to incorporate mutations and deletions and remain functional or a combination of both influences. The presence of clade-discordant residues in the progeny of individual biological sub-clones suggests limitations in the occupation of sequence space by SARS-CoV-2. However, the complex and unique mutant spectra that are rapidly generated from individual genomes suggest an aptness to confront selective constraints., The work was supported by the Ministerio de Ciencia e Innovación, grants PID2020-113888RB-I00/AEI/10.13039/501100011033 and 202220I116, by the Ministerio de Ciencia, Innovación y Universidades (MICIU), grant PID2023-146622OB-I00 financed by MICIU/AEI/10.13039/501100011033 and by FEDER, UE, through the “Severo Ochoa” Programmes for Centers of Excellence in R&D (CEX2021-001154-S and CEX2023-001386-S). The work was also supported by the European Commission Next-Generation EU (regulation EU 2020/2024) through the CSIC’s Global Health Platform (PTI Salud Global). The work was also funded by grants PI21/00139 funding from Instituto de Salud Carlos III (ISCIII), co-funded by the European Union, CSIC-COV19-014 from Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) and project 525/C/2021 from Fundació La Marató de TV3, grants 202136-30 and 202136-31. We also acknowledge the projects TEC-607 2024/BIO-66 (SALAINDEC-CM from Comunidad de Madrid/FEDER) and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBM belongs to the Global Virus Network (GVN) and to the Biomedicine Unit of Universidad de Castilla La Mancha (UCLM), associated with CSIC. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III cofinanced by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro.” P.S. is supported by postdoctoral contract Margarita Salas, CA1/RSUE/2021 from MCIU. P.M. is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CPII21/00015), cofinanced by the European Regional Development Fund (ERDF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 mutant spectrum complexity is an epidemiologically evolvable trait

  • Martínez-González, Brenda
  • Soria, María Eugenia
  • Ávila, Ana Isabel de
  • Somovilla, Pilar
  • Aguilar-Sabido, Claudia
  • Mínguez, Pablo
  • Ferrer-Orta, Cristina
  • Salar-Vidal, Llanos
  • Lorenzo-Redondo, Ramón
  • Delgado, Soledad
  • Morán, Federico
  • Verdaguer, Núria
  • Gadea, Ignacio
  • Domingo, Esteban
  • Perales, Celia
RNA virus populations consist of complex and dynamic mutant spectra in which most individual genomes differ in one or more positions from the other genomes of the same population. This behavior, known as quasispecies dynamics, applies to SARS-CoV-2 which exhibits intrahost genetic and functional heterogeneity while evolving at a high rate in the human population. In the present study, we describe a remarkable reduction in mutant spectrum complexity (intrahost viral genome heterogeneity) in SARS-CoV-2 isolates of late relative to early COVID-19 waves, as they reached Madrid (Spain) from 2020 until 2022. In contrast, the consensus (average) sequence of the corresponding isolates displayed a continuing divergence from the initial Wuhan-Hu-1 virus as the pandemic advanced. The mutant spectrum complexity developed upon replication in Vero E6 cells of the isolates from the first and sixth COVID-19 waves, as well as of biological clones retrieved from them, was similar. Therefore, the mutant spectrum complexity reduction observed in vivo was not due to an increased accuracy of the viral replicative machinery, but rather to other factors related to viral epidemiology or pathogenesis. Such possible factors and their implications for viral trait modifications in the course of a viral pandemic are discussed. The results establish that mutant spectrum complexity of genetically variable viruses can be an epidemiologically evolvable trait., This work was supported by the Spanish Ministry of Science and Innovation, grants PID2020-117976GB-I00, PID2020-113888RB-I00/AEI/10.13039/501100011033 and 202220I116, by the Ministerio de Ciencia, Innovación y Universidades (MICIU), grant PID2023-146622OB-I00 financed by MICIU/AEI/10.13039/501100011033, by Fondo Europeo de Desarrollo Regional (FEDER), UE, through the “Severo Ochoa” Program for Centres of Excellence in Research and Development (CEX2021-001154-S), and by the European Commission-Next Generation EU (regulation EU 2020/2024) through the Consejo Superior de Investigaciones Científicas (CSIC’s) Global Health Platform [Plataforma Temática Interdisciplinar (PTI) Salud Global]. The work was also funded by grants PI21/00139 from Instituto de Salud Carlos III, CSIC-COV19-014 from CSIC and project 525/C/2021 from Fundació La Marató de TV3, grants 202136-30 and 202136-31. We also acknowledge the projects TEC-2024/BIO-66 (SALAINDEC-CM from Comunidad de Madrid/FEDER) and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBM are also acknowledged. The team at Centro de Biología Molecular (CBM) belongs to the Global Virus Network, and to the Biomedicine Unit of Universidad de Castilla La Mancha, associated with CSIC. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III cofinanced by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro.” P.S. is supported by postdoctoral contract Margarita Salas, CA1/RSUE/2021 from Ministerio de Ciencia, Innovación y Universidades (MICIU). P.M. is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CPII21/00015), cofinanced by the European Regional Development Fund., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001154-S), Peer reviewed